Technology Assessment at NRC's Biotechnology Research Institute ...

beefzoologistΒιοτεχνολογία

21 Φεβ 2013 (πριν από 4 χρόνια και 3 μήνες)

108 εμφανίσεις

MEETING OF THE
FEDERAL

PARTNERS IN
TECHNOLOGY
TRANSFER


(FPTT)


NATIONAL

JUNE 1
ST

2005

EILEEN RAYMOND


INDUSTRIAL AFFAIRS

2



Plant surface



1987



19 444 m
2



2003 (now)


31 191 m
2




Personnel



Employees of BRI


CNRC



262



Guest workers




163



Students




105



Company employees




393

TOTAL 2003
-

2004

925



BRI expenses 2003
-

2004



Financed by BRI budget




$ 20 284 M



Financed by NRC special projects



$ 5 278 M



Financed by revenues generated by BRI


$ 7 352 M

3

The Biotechnology Research Institute is
committed to the mission of the National
Research Council in serving the needs of
Canadians by helping to maintain and
enhance the economic and social well
-
being of the country.

The Biotechnology Research Institute
promotes, assists and performs leading
-
edge research and development in
biochemical engineering, molecular biology
and genomics, closely linked to the needs
of the industries in the pharmaceutical and
environmental sectors.

4

Macromolecular Structure

Protein Chemistry

Enzymology

Biomolecular NMR

The Receptor, Signaling


and Proteomics

Computational Chemistry

Mammalian Cell Genetics

Genetics

Microbial & Enzymatic


Technology

Animal Cell Culture

Genomics and


Gene Therapy Vectors





Environment Genetics

Environmental Microbiology

Environmental Bioengineering

Analytical Chemistry

Biosensors

Applied Ecotoxicology

Bioconversion /


Sustainable Development



Director General

Building Engineer

Finance & Administration

Human Resources

Industrial Affairs

Director


Health Director


Bioprocess

Director

Environment Director

5

44%
46%
10%
Active agreements
with industrial partners
Active agreements
with governmental
organizations
Active agreements
with universities


31 new collaboration agreements



50 active collaboration agreements



46 canadian partners (92%)







Distribution of active collaboration
agreements in 2003
-
2004

COLLABORATIONS

6

IP COMMITTEES

Background 2001

Comments 2005



Author



Andy Storer


Director Health Sector



NRC IPMC Meeting at
BRI



First IP Committee
September 1999

7

IP COMMITTEES

Background 2001

Comments 2005



Bottleneck in
Technology Transfer
(Resources)



Need to strenghten
technologies for
patenting













2005

8

IP COMMITTEES

Background 2001

Comments 2005



Paperwork issues at the
beginning



Implemented to
Bioprocess and
Environment Sectors
(2001)



Follow
-
up of actions
difficult for a long time



Structure changes
needed



2004/2005 model :
mature and functional

9

IP COMMITTEES

Background 2001

Comments 2005



No change

10

IP COMMITTEES

Background 2001

Comments 2005



No change


11

IP COMMITTEES

Background 2001

Comments 2005



Number of total
presentations has
dropped through the years



Number of publications
maintained



More

"parcels" of
research presented
(gaining 6 months earlier)



Comparison checks need
to be done Publications vs
Presentations



Issues with principal
authors outside

12

IP COMMITTEES

Background 2001

Comments 2005



On the spot with the right
people, open discussion
for screening decision
(hold or publish) using
simplified criteria:


1
º Patentability: new,
useful, non obvious
(Form 1)


2º Some intuitive market
rational


3º Follow
-
up on research


If more info is needed,
postpone decision to
next month

13

IP COMMITTEES

Background 2001

Comments 2005



Duly completed
Form 1

and manuscripts are
assessed to ensure
sufficient data is
provided to support a
useful scope of claims
for patent applications

14

IP COMMITTEES

Background 2001

Comments 2005



Improvement ongoing
for timeline of tasks and
actions



15

IP COMMITTEES

Background 2001

Comments 2005



Paperwork issues


Coordination issues


Follow
-
up on actions
issues


Marketing resources
issues


For a long time still
reactive mode facing
deadlines



16

IP COMMITTEES

Background 2001

Comments 2005



For few years, number
of files increased



Number of files
decreased to reach a
plateau due to better
selectivity



Better management
for older files
including dropping
cases when
appropriate



Knowledgeable
scientists on IP
issues









2005

17

IP COMMITTEES

Background 2001

Comments 2005



First IP Committee


September 1999



Prior to 1999, few files



Following the growth, a
switch from quantity to
quality




18

IP COMMITTEES

Background 2001

Comments 2005



Cost control was reached in
2004



Less files and better control
(IP AUDIT)



Culture shift allows the IP
integration within daily R&D
work



A Patent is not something on
the side for anyone!



Need to link IP Management
and Project Management



Need resources for
technology assessment,
marketing and technology
transfer





2005

19

IP Committees (2004 / 2005 Model)

IP COMMITTEE

Operation



1 committee per Scientific Sector


Environment, Bioprocess, Health)



1 monthly meeting in 2 parts



Scientific presentation (open to all)


PART 1


Decision on protection and/or publication



IP portfolio management


PART 2


Controlling fees and follow
-
ups on files, with actions of protection and marketing



Composition :



Sector Director (presides meeting)



Director of Industrial Affairs



Group leaders (3 permanents/18 months)



1 Patent Agent (IPS Ottawa)



1 IP Coordinator



2 Business Development Officers (BDOs)



Separate work
-
meetings for prioritary files



Valuation of technology



Strategy and actions to ensure Technology Transfer



20

Business Affairs
Opportunity (1 pager)

21

Business Affairs
Opportunity (1 pager)